New daily pill shows promise for Hard-to-Treat leukemia
Disease control
Recruiting now
This study tests a new daily pill called TERN-701 for adults with chronic myeloid leukemia (CML) who have not responded well to other treatments. The trial has two parts: first, finding the safest dose, then testing that dose in more people. About 180 participants will take the p…
Phase: PHASE1, PHASE2 • Sponsor: Terns, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC